Latest filing published 15 Jul 2026 for Nuvalent, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Ron Squarer: trading record in brief
Filings by Ron Squarer span 5 companies, the busiest being Array Biopharma Inc, Hospira Inc and Travere Therapeutics, Inc. The record holds 67 filings, for trades running from 25 February 2009 to 15 July 2026.
Both buying and selling appear: 1 purchase worth €58k, against 11 sales worth €17.7M. On balance, insiders were net sellers of €17.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 29 share grants and 21 option exercises.
The record was last updated on 15 July 2026 with a transaction in Nuvalent, Inc. The clock since the last published purchase (26 February 2009) now reads 6,464 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ron Squarer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,281 sharesClass A Common Stock - Restricted Stock UnitsSEC:0001193125-26-305080:0
- 45,000 shares0Common SharesSEC:0001628280-26-040492:0
- 15,196 shares@ US$3.0838.0% of flowCommon SharesSEC:0001628280-26-040492:1
- 2,837 shares0Class A Common StockSEC:0001193125-25-316060:0
- 15,184 shares@ US$3.5844.2% of flowCommon SharesSEC:0001628280-25-031895:0
- 40,000 shares0Common SharesSEC:0001628280-25-029724:0
- 6,500 shares0Common StockSEC:0001415889-25-013503:0
- 6,995 shares@ US$2.8917.8% of flowCommon SharesSEC:0001628280-24-028987:0
- 40,000 shares0Common SharesSEC:0001628280-24-028343:0
- 6,500 shares0Common StockSEC:0001415889-24-012851:0
- 4,500 shares0Common StockSEC:0001209191-23-030950:0
- 3,000 shares0Common StockSEC:0001209191-22-028703:0
- 3,000 shares0Common StockSEC:0001209191-21-033845:0
- 3,000 shares0Common StockSEC:0001209191-20-030750:0
- 442,190 sharesCommon StockSEC:0001209191-19-043786:1
- 259,891 shares@ US$48.0058.9% of flowCommon StockSEC:0001209191-19-043786:0
- 2,000 shares0Common StockSEC:0001209191-19-029159:0
- 37,813 shares0Common StockSEC:0001562180-19-002183:0
- 16,631 shares@ US$24.601.6% of flowCommon StockSEC:0001562180-19-002183:1
- 110,000 shares@ US$3.611.5% of flowCommon StockSEC:0001562180-19-000859:0
- 110,000 shares@ US$21.648.9% of flowCommon StockSEC:0001562180-19-000859:1
- 100,000 shares@ US$3.611.3% of flowCommon StockSEC:0001562180-19-000687:0
- 100,000 shares@ US$18.256.8% of flowCommon StockSEC:0001562180-19-000687:1
- 113,438 shares@ US$7.303.1% of flowCommon StockSEC:0001562180-19-000687:2
- 113,438 shares@ US$18.537.8% of flowCommon StockSEC:0001562180-19-000687:3
25 of 67 declarations
